Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7480-7488

  Murugaiyan, Gopal ^a   Mittal, Akanksha ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN RECEPTOR; BETA3 INTEGRIN; CD44 RECEPTOR; CD51 ANTIGEN; CYTOKINE RECEPTOR; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; LYMPHOCYTE ANTIGEN RECEPTOR; OSTEOPONTIN; OSTEOPONTIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; HUMAN CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 71849086031     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7480     Document Type: Article

References (33)

1. Denhardt, D. T., M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107: 1055-1061.
2. Gravallese, E. M. 2003. Osteopontin: a bridge between bone and the immune system. J. Clin. Invest. 112: 147-149.
3. Chabas, D., S. E. Baranzini, D. Mitchell, C. C. Bernard, S. R. Rittling, D. T. Denhardt, R. A. Sobel, C. Lock, M. Karpuj, R. Pedotti, et al. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294: 1731-1735. (Pubitemid 33104847)
4. Comabella, M., I. Pericot, R. Goertsches, C. Nos, M. Castillo, J. Blas Navarro, J. Rio, and X. Montalban. 2005. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol. 158: 231-239. (Pubitemid 39626091)
5. Wong, C. K., L. C. Lit, L. S. Tam, E. K. Li, and C. W. Lam. 2005. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology 44: 602-606. (Pubitemid 41487227)
6. Sato, T., T. Nakai, N. Tamura, S. Okamoto, K. Matsuoka, A. Sakuraba, T. Fukushima, T. Uede, and T. Hibi. 2005. Osteopontin/Eta-1 up-regulated in Crohn's disease regulates the Th1 immune response. Gut 54: 1254-1262. (Pubitemid 41192483)
7. Aspord, C., S. Rome, and C. Thivolet. 2004. Early events in islets and pancreatic lymph nodes in autoimmune diabetes. J. Autoimmun. 23: 27-35. (Pubitemid 38953790)
8. Shin, T., M. Ahn, H. Kim, H. M. Kim, and Y. Matsumoto. 2006. Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis. J. Vet. Med. Sci. 68: 379-382. (Pubitemid 44575081)
9. Jansson, M., V. Panoutsakopoulou, J. Baker, L. Klein, and H. Cantor. 2002. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/ osteopontin-deficient mice. J. Immunol. 168: 2096-2099. (Pubitemid 34171807)
10. Vogt, M. H., S. Floris, J. Killestein, D. L. Knol, M. Smits, F. Barkhof, C. H. Polman, and L. Nagelkerken. 2004. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J. Neuroimmunol. 155: 155-160. (Pubitemid 39165788)
11. Hur, E. M., S. Youssef, M. E. Haws, S. Y. Zhang, R. A. Sobel, and L. Steinman. 2007. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8: 74-83.
12. Stromnes, I. M., and J. M. Goverman. 2007. Osteopontin-induced survival of T cells. Nat. Immunol. 8: 19-20.
13. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864. (Pubitemid 30084330)
14. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
15. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7. (Pubitemid 3024744)
16. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. Th-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350. (Pubitemid 46745409)
17. Vaknin-Dembinsky, A., K. Balashov, and H. L. Weiner. 2006. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176: 7768-7774. (Pubitemid 43849078)
18. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
19. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
20. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by Th1 and Th17 cells. Nat. Med. 14: 337-342.
21. Manuel, S. L., S. Rahman, B. Wigdahl, Z. K. Khan, and P. Jain. 2007. Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front. Biosci. 12: 4315-4335.
22. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
23. + T helper cells. Cell 126: 1121-1133.
24. Shinohara, M. L., M. Jansson, E. S. Hwang, M. B. Werneck, L. H. Glimcher, and H. Cantor. 2005. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. USA 102: 17101-17106. (Pubitemid 41692690)
25. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human Th-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9: 641-649. (Pubitemid 351714729)
26. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
27. Chen, Y., C. L. Langrish, B. McKenzie, B. Joyce-Shaikh, J. S. Stumhofer, T. McClanahan, W. Blumenschein, T. Churakovsa, J. Low, L. Presta, et al. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116: 1317-1326.
28. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
29. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
30. Li, Q., J. D. Lifson, L. Duan, T. W. Schacker, C. Reilly, J. Carlis, J. D. Estes, and A. T. Haase. 2005. Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection. J. Infect. Dis. 192: 1269-1276. (Pubitemid 41368429)
31. Renkl, A. C., J. Wussler, T. Ahrens, K. Thoma, S. Kon, T. Uede, S. F. Martin, J. C. Simon, and J. M. Weiss. 2005. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106: 946-955.
32. Miller, S. D., E. J. McMahon, B. Schreiner, and S. L. Bailey. 2007. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 1103: 179-191.
33. Sobel, R. A., J. R. Hinojoza, A. Maeda, and M. Chen. 1998. Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions. Am. J. Pathol. 153: 405-415.